SCHEMBL24325814

SCHEMBL24325814

CN(Cc1ccccc1)C[C@H](O)CN(C)C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.46
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43
TSHR P16473 2/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
RIPK1 Q13546 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
AKT1 P31749 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AGER Q15109 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1529700 0.85 ATM (0.43) HTR2CSLC6A4CTSLCTSBCTSS
SCHEMBL8193756 0.83 HTR2C (0.43) HTR2CSLC6A4TSHRCTSLCTSB
SCHEMBL7965436 0.83 TSHR (0.43) HTR2CSLC6A4TSHRCTSLCTSB
SCHEMBL7190668 0.81 RIPK1 (0.57) HTR2CSLC6A4CTSLCTSBCTSS
SCHEMBL7053417 0.81 CA1 (0.50) HTR2CSLC6A4CTSSRAB9ACA9
SCHEMBL24323788 0.81 CA1 (0.50) HTR2CSLC6A4CTSSRAB9ACA9
SCHEMBL20715723 0.80 SLC6A4 (0.49) HTR2CSLC6A4CTSLCTSBCTSS
SCHEMBL24323548 0.80 SYK (0.50) DNM1CTSLCTSBCTSSAKT1
SCHEMBL1447140 0.80 HDAC6 (0.36) HTR2CSLC6A4CTSLCTSBCTSS
SCHEMBL13215429 0.78 SIGMAR1 (0.49) MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed